IPVS Policy statement on safety of HPV vaccines.
机构信息
.
出版信息
Papillomavirus Res. 2016 Dec;2:9-10. doi: 10.1016/j.pvr.2015.11.001. Epub 2015 Dec 2.
Abstract
摘要
相似文献
1
IPVS Policy statement on safety of HPV vaccines.免疫规划疫苗咨询委员会关于人乳头瘤病毒疫苗安全性的政策声明。
Papillomavirus Res. 2016 Dec;2:9-10. doi: 10.1016/j.pvr.2015.11.001. Epub 2015 Dec 2.
2
Investigational 9-valent HPV vaccine could prevent almost 90% of cervical cancers.研究性九价人乳头瘤病毒疫苗可预防近90%的宫颈癌。
Hum Vaccin Immunother. 2014;10(11):3105-6.
3
Greatest effect of HPV vaccination from school-based programmes.基于学校的人乳头瘤病毒（HPV）疫苗接种计划效果最佳。
Lancet Infect Dis. 2015 May;15(5):497-8. doi: 10.1016/S1473-3099(15)70078-2. Epub 2015 Mar 3.
4
Current clinical trials of HPV vaccines.人乳头瘤病毒疫苗的当前临床试验。
Oncology (Williston Park). 2004 Jun;18(7):859-60, 862.
5
HPV and cervical cancer in the 2007 report.2007年报告中的人乳头瘤病毒与宫颈癌
Vaccine. 2007 Nov 1;25 Suppl 3:C1-230. doi: 10.1016/S0264-410X(07)01183-8.
6
HPV vaccination: the beginning of the end of cervical cancer? - A Review.人乳头瘤病毒疫苗接种：宫颈癌终结的开端？——综述
Mem Inst Oswaldo Cruz. 2009 Feb;104(1):1-10. doi: 10.1590/s0074-02762009000100001.
7
Australian HPV vaccination programme yields results.澳大利亚人乳头瘤病毒疫苗接种计划取得成效。
Lancet Oncol. 2014 Dec;15(13):e591. doi: 10.1016/S1470-2045(14)71039-3. Epub 2014 Nov 7.
8
HPV vaccines: what remains to be done? Interview by Lauren Constable.人乳头瘤病毒疫苗：仍需做些什么？劳伦·康斯特布尔访谈
Expert Rev Vaccines. 2011 Nov;10(11):1505-7. doi: 10.1586/erv.11.128.
9
Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.调节 HPV 感染和 HPV 导向免疫治疗期间的免疫反应。
Immunol Rev. 2011 Jan;239(1):85-98. doi: 10.1111/j.1600-065X.2010.00966.x.
10
Clinical approval: Trials of an anticancer jab.临床批准：一种抗癌注射剂的试验。
Nature. 2012 Aug 30;488(7413):S4-6. doi: 10.1038/488S4a.
引用本文的文献
1
Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16-26 years in Chongqing, China.中国重庆 16-26 岁人群中九价人乳头瘤病毒（HPV）疫苗上市后安全性监测研究。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2281700. doi: 10.1080/21645515.2023.2281700. Epub 2023 Dec 19.
2
Invited Commentary: Moving From Evidence to Impact for Human Papillomavirus Vaccination-The Critical Role of Translation and Communication in Epidemiology.特邀评论：从 HPV 疫苗接种的证据到影响——在流行病学中翻译和沟通的关键作用。
Am J Epidemiol. 2018 Jun 1;187(6):1277-1280. doi: 10.1093/aje/kwy024.
3
Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.九价人乳头瘤病毒疫苗的功效、免疫原性和安全性：来自亚洲国家参与者的亚组分析。
J Infect Dis. 2018 Jun 5;218(1):95-108. doi: 10.1093/infdis/jiy133.
4
HPV vaccination of immunocompromised hosts.免疫功能低下宿主的人乳头瘤病毒疫苗接种
Papillomavirus Res. 2017 Dec;4:35-38. doi: 10.1016/j.pvr.2017.06.002. Epub 2017 Jun 3.
5
Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline.宫颈癌的一级预防：美国临床肿瘤学会资源分层指南
J Glob Oncol. 2017 Mar 17;3(5):611-634. doi: 10.1200/JGO.2016.008151. eCollection 2017 Oct.
6
Cervical Cancer Prevention Through HPV Vaccination in Low- and Middle-Income Countries in Asia.亚洲低收入和中等收入国家通过人乳头瘤病毒疫苗接种预防宫颈癌
Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2339-2343. doi: 10.22034/APJCP.2017.18.9.2339.
7
Human papillomavirus vaccination: the population impact.人乳头瘤病毒疫苗接种：对人群的影响
F1000Res. 2017 Jun 12;6:866. doi: 10.12688/f1000research.10691.1. eCollection 2017.
8
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience.四价人乳头瘤病毒疫苗的影响与效果：对十年真实世界经验的系统评价
Clin Infect Dis. 2016 Aug 15;63(4):519-27. doi: 10.1093/cid/ciw354. Epub 2016 May 26.
本文引用的文献
1
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.四价人乳头瘤病毒疫苗安全性概述：2006年至2015年
Pediatr Infect Dis J. 2015 Sep;34(9):983-91. doi: 10.1097/INF.0000000000000793.
2
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.四价人乳头瘤病毒疫苗接种与多发性硬化症及其他中枢神经系统脱髓鞘疾病的风险。
JAMA. 2015 Jan 6;313(1):54-61. doi: 10.1001/jama.2014.16946.
3
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases.疫苗与多发性硬化症和其他中枢神经系统脱髓鞘疾病的风险。
JAMA Neurol. 2014 Dec;71(12):1506-13. doi: 10.1001/jamaneurol.2014.2633.
4
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.2007 - 2013年美国青少年人乳头瘤病毒疫苗接种覆盖率及2006 - 2014年疫苗上市后安全性监测
MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-4.
5
Safety of HPV vaccination: a FIGO statement.人乳头瘤病毒疫苗接种的安全性：一份国际妇产科联盟声明。
Int J Gynaecol Obstet. 2013 Dec;123(3):187-8. doi: 10.1016/j.ijgo.2013.09.009. Epub 2013 Sep 13.
Zotero 插件